Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe study record page now displays a 403 Forbidden error, indicating the content is not accessible. This change blocks access to the NCT03525678 study details on ClinicalTrials.gov and updates the page header to reflect the error.SummaryDifference22%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision was updated to v3.6.6, a 2017 NIH funding note was added, and a new bibliographic citation (Tacchetti et al., Expert Rev Anticancer Ther, 2024) was included to reference recent literature related to antibody-drug conjugates in multiple myeloma.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page gains new contextual references to the disease (Multiple myeloma) and related topics, including a MedlinePlus Genetics link, expanding readers' access to related information.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor update to the study record. This update does not alter the underlying study data or claims.SummaryDifference0.0%

- Check51 days agoChange DetectedRelated topics section entries were removed: 'Multiple myeloma' and 'MedlinePlus Genetics', and the 'related topics' label was deleted. This changes how users access condition-specific information and external resources from the study page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page shows Revision: v3.6.4, replacing Revision: v3.6.3, indicating a template/update of the page framework without changes to the study content.SummaryDifference0.0%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.